Salama Ali
By disease, the biomarkers market comprises immunological diseases, cancer, neurological diseases, cardiovascular diseases, and others. The cancer segment dominates the global biomarkers market, due to the growing demand for accurate and rapid diagnostic tools and rising cancer incidences globally. According to the National Cancer Institute, about 268,670 new cases of breast cancer were recorded in 2018 in the U.S
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi